Inhalon Biopharma

company

About

Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$7M
Industries
Biopharma,Biotechnology
Founded date
Oct 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Inhalon Biopharma is into developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$7M
Inhalon Biopharma has raised a total of $7M in funding over 2 rounds. Their latest funding was raised on May 26, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 26, 2021 Grant $7M 1 U.S. Army Medical Research & Development Command Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Inhalon Biopharma is funded by 1 investors. U.S. Army Medical Research & Development Command are the most recent investors.
Investor Name Lead Investor Funding Round
U.S. Army Medical Research & Development Command Yes Grant